| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 06/22/2005 | EP1082127B1 Succinamide inhibitors of interleukin-1beta converting enzyme |
| 06/22/2005 | EP0973554B1 Chelating agents |
| 06/22/2005 | CN1630646A Optically active azole derivative and process for producing the same |
| 06/22/2005 | CN1630643A Substituted benzoylcyclohexane diones for use as herbicides |
| 06/22/2005 | CN1630517A CXCR4-antagonistic drugs composed of nitrogen-containing compound |
| 06/22/2005 | CN1629144A Method for preparing rilrnenidine |
| 06/22/2005 | CN1207289C Metalloproteinase inhibitors, pharmaceutical compositions containing the same and their pharmaceutical uses, and methods and intermediates useful for their preparation |
| 06/22/2005 | CN1207288C Retroviral protease inhibiting compounds |
| 06/22/2005 | CN1207286C Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds |
| 06/22/2005 | CN1207271C Aminoacid-iodine complex |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/22/2005 | CN1206914C Pesticide containing 0-benzyl oximeether derivative and its use |
| 06/21/2005 | US6909014 Intermediates for the synthesis of ether compounds |
| 06/21/2005 | US6908940 Imidazole compounds and their use as adenosine deaminase inhibitors |
| 06/21/2005 | US6908938 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 06/21/2005 | US6908935 Calcium receptor modulating agents |
| 06/21/2005 | US6908752 Generation of preferential particle; obtain chemical intermediates, inubate wit reaction mixture and enzyme, recover and separate preferential particles |
| 06/21/2005 | US6908493 1-(2,4-Diamino-phenoxy)-3-aminopropan-2-ol derivatives |
| 06/16/2005 | WO2005055286A2 Zwitterionic compounds and photovoltaic cells containing same |
| 06/16/2005 | WO2005054206A1 Histidine derivatives |
| 06/16/2005 | WO2005054179A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/16/2005 | US20050131227 Synthesis of temozolomide and analogs |
| 06/16/2005 | US20050131043 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 06/16/2005 | US20050131042 HIV protease inhibiting compounds |
| 06/16/2005 | US20050130966 Sodium channel modulators |
| 06/16/2005 | US20050130941 Methods of treating alzheimer's disease |
| 06/16/2005 | CA2549242A1 Hydroxamic acid esters and pharmaceutical use thereof |
| 06/15/2005 | EP1541692A1 PROCESS FOR PRODUCING L-a-METHYLCYSTEINE DERIVATIVE |
| 06/15/2005 | EP1539740A1 Sulphonamide derivatives and their use as tace inhibitors |
| 06/15/2005 | EP1539707A1 Method and compounds for promoting healing and reducing inflammation |
| 06/15/2005 | EP1539706A1 1-sulphonyl piperidine derivatives |
| 06/15/2005 | EP1539685A1 Mcp-1 receptor antagonists and method of use thereof |
| 06/15/2005 | EP1539683A2 Phenol derivatives and their use as rotamase inhibitors |
| 06/15/2005 | EP1539662A1 Cannabinoid receptor ligands |
| 06/15/2005 | EP1256576B1 Fused imidazolium derivatives |
| 06/15/2005 | EP1020451B1 Anilide compounds and drugs containing the same |
| 06/15/2005 | EP0991654B1 Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 06/15/2005 | EP0975602B1 Imidazole and imidazoline derivatives and uses thereof |
| 06/15/2005 | CN1626540A Iridium compound and organic electroluminescent device using the same |
| 06/15/2005 | CN1626532A Amide compounds |
| 06/15/2005 | CN1626521A Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage |
| 06/15/2005 | CN1626513A Organometallic complexes and organic electroluminescence device using the same |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/14/2005 | US6906079 Method and reagents for N-alkylating ureides |
| 06/14/2005 | US6906070 Anticoagulants |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/09/2005 | WO2005051892A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines |
| 06/09/2005 | WO2005028425A3 Amidines and derivatives thereof and pharmaceutical compositions containing them |
| 06/09/2005 | US20050124837 Preparation of alkenylaromatic compounds |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124677 Peptide deformylase inhibitors |
| 06/09/2005 | US20050124671 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 06/09/2005 | US20050124654 Compounds and methods of use |
| 06/09/2005 | US20050124578 Aqueous compositions containing metronidazole |
| 06/09/2005 | US20050124561 Administering fungicide for mucous membrane; asthma therapy |
| 06/09/2005 | US20050123831 used for ionic conducting materials, electronic conducting materials, colorant, and the catalysis of various chemical reactions |
| 06/09/2005 | US20050123533 Prodrugs activated by targeted catalytic proteins |
| 06/09/2005 | CA2547281A1 Novel phenoxyacetamide derivatives and use thereof for the preparation of diphenylamines |
| 06/09/2005 | CA2546733A1 A2b adenosine receptor antagonists |
| 06/08/2005 | EP1537074A1 Cathepsin cysteine protease inhibitors |
| 06/08/2005 | EP1536812A2 Methods for modulating activity of the fxr nuclear receptor |
| 06/08/2005 | EP1536787A2 Imidazole alkaloids from lepidium meyenii and methods of usage |
| 06/08/2005 | EP1465854A4 Chalcone derivatives and their use to treat diseases |
| 06/08/2005 | EP1057816B1 Method for producing heteroaromatic aldehydes |
| 06/08/2005 | EP1042305B1 INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS |
| 06/08/2005 | CN1205202C N-carbanilides used as pesticides |
| 06/08/2005 | CN1205191C Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists |
| 06/08/2005 | CN1205186C ACE inhibitor nitric salts |
| 06/08/2005 | CN1205180C 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 06/08/2005 | CN1205179C (P-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 06/08/2005 | CN1205176C Stable salts of o-acetylsalicyclic with basic amino acids |
| 06/08/2005 | CN1205153C Method for producing molecular compound |
| 06/07/2005 | US6903220 Synthesis of chiral 2-alkyl amino acids |
| 06/07/2005 | US6903218 Substituted or unsubstituted aryl-1-hydroxyethylaminocarbonylalkyl-chroman-sulfonamide compounds are useful in the treatment of beta-3 receptor mediated conditions |
| 06/07/2005 | US6903215 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/07/2005 | US6903133 Anticancer compounds |
| 06/07/2005 | US6903128 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 06/07/2005 | US6903092 Naphthamide neurokinin antagonists for use as medicaments |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/02/2005 | WO2005049594A1 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049593A2 N-acylsulfonamide apoptosis promoters |
| 06/02/2005 | WO2005049580A1 Monocyclic n-aryl hydantoin modulators of androgen receptor function |
| 06/02/2005 | US20050119502 (Dialkylamino, morpholino, or imidazolyl)-alkoxyphenolic derivatives as drug delivery agents; improved bioavailability for oral administration |
| 06/02/2005 | US20050119333 Compositions comprising ether compounds and pharmaceutical uses therefor |
| 06/02/2005 | US20050119312 Lipid lowering agents; hypotensive agents; obesity |
| 06/01/2005 | EP1534693A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 06/01/2005 | EP1534686A2 Nf-kb inhibitors and uses thereof |
| 06/01/2005 | EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 06/01/2005 | EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use |
| 06/01/2005 | EP1534273A2 Modulators of the glucocorticoid receptor and method |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1254136A4 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 06/01/2005 | EP1009758B1 Meta-benzamidine derivatives as serine protease inhibitors |
| 06/01/2005 | CN1622948A Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 06/01/2005 | CN1622940A Onium salts with weakly coordinating imidazolidine anion as cationic initiators |
| 06/01/2005 | CN1622925A Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 06/01/2005 | CN1204118C Comprehensive cystine mother liquor utilizing process of producing single amino acid and eliminating pollution |
| 05/31/2005 | US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis |
| 05/31/2005 | US6900218 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 05/31/2005 | US6900213 Controlling fertility; contraceptives; anticancer agents |